Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer

April 7, 2020 Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma

The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …
News
fda2outsideweb

FDA approval for BMS and Acceleron’s Reblozyl to reduce red blood cell transfusion dependence

April 6, 2020 Manufacturing and Production, Sales and Marketing BMS, FDA, Reblozyl, pharma

The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” …
News
00000000_kockk

British Health Secretary says more patients with COVID-19 are needed for clinical trials

April 6, 2020 Sales and Marketing COVID-19, UK, clinical trials, coronavirus

Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials …
News
novo_nordisk_flag

European approval for Novo’s Rybelsus to control blood sugar in type 2 diabetes

April 6, 2020 Sales and Marketing Novo Nordisk, Rybelsus, diabetes, pharma

The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic …
News
00000000_trumpyy

Trump again tells people to take Hydroxychloroquine to treat COVID-19, despite a lack of evidence

April 6, 2020 Sales and Marketing COVID-19, chloroquine, coronavirus, hydrochloroquine, hydroxychloroquine

President Trump continues to push the drug hydroxychloroquine as a potential coronavirus treatment despite a lack of evidence for its …
News

Pfizer scores EU approval for MabThera biosimilar Ruxience

April 6, 2020 Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar

The European Commission has moved to authorise Ruxience, Pfizer’s biosimilar version of MabThera (rituximab).  The decision marks the seventh biosimilar …
News
david_setboun

Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …
Appointment
john-mckew-big

Dr John C. McKew promoted to Chief Operating Officer at Lumos Pharma

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lumos Pharma, Inc. has promoted Dr John McKew to the position of Chief Operating Officer effective 1 April 2020. McKew …
Appointment
alimera_sciences_logo

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …
Appointment
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has …
News
blood-75301_1280

US approval for haemophilia drug derived from genetically engineered rabbit’s milk

April 2, 2020 Sales and Marketing FDA, US, haemophilia, pharma

The FDA has announced the approval of Sevenfact, a haemophilia therapy the active ingredient from which is expressed in genetically …
News
pharmafocus_april_2020_cover

The April 2020 issue of Pharmafocus is available to read free online now!

April 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data

The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
News
medications-257333_640

People or profit: What is the best system to regulate drug prices?

March 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
Feature
astrazeneca_building_white

FDA immunotherapy first with the approval of AZ’s Imfinzi in first-line extensive-stage small cell lung cancer

March 30, 2020 Sales and Marketing AstraZeneca, Cancer, FDA, Imfinzi, lung cancer, pharma

AstraZeneca has seized FDA approval for its immune checkpoint inhibitor Imfinzi (durvalumab) in the first-line treatment of extensive-stage small cell …
News

EMA gives market authorisation application to epilepsy treatment from Arvelle Therapeutics

March 30, 2020 Sales and Marketing EMA, EMA approvals, approvals, epilepsy

The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for a cenobamate adjunctive treatment of focal-onset seizures …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025